Innovative AI Solutions Cleerly's cutting-edge AI-powered cardiovascular imaging technology offers significant opportunities to expand into healthcare providers and hospitals seeking advanced diagnostic tools for heart disease, emphasizing its unique value proposition in non-invasive, precise coronary artery assessment.

Strong Industry Presence Active participation in high-profile conferences like TCT and ACC.25 highlights Cleerly’s reputation and ongoing engagement with key opinion leaders, enabling sales teams to leverage their thought leadership and recent scientific breakthroughs to build credibility with potential clients.

Strategic Collaborations Recent integration with Cardiac Care Alliance and partnership with Bunkerhill Health signal growth opportunities through collaborative sales efforts, allowing penetration into established cardiovascular care networks and expanding access to AI-driven diagnostics.

Robust Funding & Growth With over 50 million dollars raised in Series C funding from prominent investors like Insight Partners and Battery Ventures, Cleerly is positioned for rapid expansion and product deployment, creating opportunities for vendors and partners aligned with scaling innovative healthcare solutions.

Market Reputation & Research Cleerly's scientific leadership, exemplified by the hiring of a chief scientific officer and presentation of late-breaking science, enhances its appeal to health systems prioritizing evidence-based, scientifically validated diagnostic solutions, thus opening doors for evidence-driven sales approaches.